TY  - GEN
AU  - Frost,Adaani E
AU  - Barst,Robyn J
AU  - Hoeper,Marius M
AU  - Chang,Hyuk-Jae
AU  - Frantz,Robert P
AU  - Fukumoto,Yoshihiro
AU  - Galié,Nazzareno
AU  - Hassoun,Paul M
AU  - Klose,Hans
AU  - Matsubara,Hiromi
AU  - Morrell,Nicholas W
AU  - Peacock,Andrew J
AU  - Pfeifer,Michael
AU  - Simonneau,Gérald
AU  - Tapson,Victor F
AU  - Torres,Fernando
AU  - Dario Vizza,Carmine
AU  - Lawrence,David
AU  - Yang,Wei
AU  - Felser,James M
AU  - Quinn,Deborah A
AU  - Ghofrani,Hossein-Ardeschir
TI  - Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
SN  - 1557-3117
PY  - 2016///0816
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Exercise Tolerance
KW  - physiology
KW  - Female
KW  - Follow-Up Studies
KW  - Hemodynamics
KW  - drug effects
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - drug therapy
KW  - Imatinib Mesylate
KW  - administration & dosage
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - Retrospective Studies
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.healun.2015.05.025
ER  -